AUA2019 076IC - Advanced OAB Therapies - What To Do When 1st And 2nd Line Therapies Do Not Work
AUAUniversity30 Touko 2019

AUA2019 076IC - Advanced OAB Therapies - What To Do When 1st And 2nd Line Therapies Do Not Work

Support provided by an independent educational grant from Allergan, Astellas and Medtronic CME Available: https://auau.auanet.org/node/24581 Instructional Course Director(s) Kathleen Kobashi, MD, FACS, FPMRS Virginia Mason Medical Center Instructional Course Faculty(s) Sandip Vasavada, MD Professor of Surgery/Urology Cleveland Clinic Glickman Urological Institute and Lerner College of Medicine David Ginsberg, MD USC Institute of Urology This course would aim to discuss all guidelines-approved 3rd line therapies for the treatment of overactive bladder (OAB). Case–based discussion will be used adjunctively to illustrate how best to select patients in varying clinical scenarios and how to optimally counsel a patient on each of the available modalities, including onabotulinumtoxinA injection of the bladder, tibial nerve stimulation, and sacral nerve stimulation (SNS). Emerging therapies in neuromodulation will also be introduced. Optimal patient selection and integration of these therapies into the urology practice will be discussed in detail. Importantly, the technique of onabotulinumtoxinA injection, ideal tibial nerve stimulation, optimal SNS lead placement, and troubleshooting of the failed implant will be highlighted. Learning Objectives: Name the available 3rd line therapies for treatment of refractory OAB Practice the the injection technique for onabotulinumtoxinA for OAB Employ the technique of tibial nerve stimulation for OAB Indicate the optimal lead placement for sacroneuromodulation and troubleshooting the failed implant Identify the upcoming 3rd line therapies for OAB

Jaksot(422)

Highlights in Renal Cell Carcinoma: The Evolving Landscape of Adjuvant Therapy (2018)

Highlights in Renal Cell Carcinoma: The Evolving Landscape of Adjuvant Therapy (2018)

The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on: Discussing the evolving landscape of adjuvant therapy for the treatment ...

8 Kesä 201842min

Highlights in Renal Cell Carcinoma: The Roles of the Urologist and Medical Oncologist (2018)

Highlights in Renal Cell Carcinoma: The Roles of the Urologist and Medical Oncologist (2018)

The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on: Discussing the evolving landscape of adjuvant therapy for the treatment ...

31 Touko 201841min

AUA2018 074IC - AUA CRPC Guidelines

AUA2018 074IC - AUA CRPC Guidelines

This course will review the 2015 update to the 2013 AUA guidelines on castration-resistant prostate cancer. Faculty will explore the rigorous process used in the development of these evidence-based gu...

23 Touko 20181h 56min

AUA2018 Contemporary Pharmacotherapy for OAB

AUA2018 Contemporary Pharmacotherapy for OAB

The American Urological Association (AUA) recognizes the critical role of the primary care provider in treating patients with urologic conditions. The AUA is pleased to offer this Podcast on one of th...

19 Touko 201859min

Minimally Invasive Treatment Of BPH

Minimally Invasive Treatment Of BPH

Steven A Kaplan, MD joins Dr. Nitti to discuss Minimally Invasive Treatment Of BPH. Dr. Kaplan is Professor of Urology at the Icahn School of Medicine at Mount Sinai and Director of Benign Urologic D...

22 Helmi 201834min

Update on Medical and Surgical Management of Advanced Testis Cancer

Update on Medical and Surgical Management of Advanced Testis Cancer

Dr Nitti and Dr. Daneshmand discuss the AUA Update Series Article titled "Update on Medical and Surgical Management of Advanced Testis Cancer" This episode will describe and explain the current recom...

31 Tammi 201839min

AUA2017 Court is in Session: Sepsis after Mini PNCL

AUA2017 Court is in Session: Sepsis after Mini PNCL

AUA2017 Court is in Session: Sepsis after Mini PNCL by American Urological Association

18 Tammi 201858min

CRPC Sequencing Agents

CRPC Sequencing Agents

Dr. Tanya D. Dorff presentation on Treatment Sequencing and Combinatorial Strategies in CRPC Acknowledgements The AUA Office of Education would like to thank the companies who support continuing educ...

20 Joulu 201735min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-narsisti
rss-niinku-asia-on
adhd-podi
rss-liian-kuuma-peruna
aamukahvilla
psykologia
rss-valo-minussa-2
rss-vapaudu-voimaasi
kesken
rss-koira-haudattuna
aloita-meditaatio
dear-ladies
esa-saarinen-filosofia-ja-systeemiajattelu
ihminen-tavattavissa-tommy-hellsten-instituutti
leveli
rss-luonnollinen-synnytys-podcast
filocast-filosofian-perusteet